Outpatient Alternatives for Youth Suicide Risk
(SOARS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different methods to assist youth with acute suicidal thoughts or those who have attempted suicide in the past month. It compares several treatment combinations, including short therapy sessions, caregiver coaching, and safety planning, to determine which most effectively reduces suicidal thoughts and behaviors. One treatment under evaluation is the Swift Outpatient Alternatives for Rapid Stabilization (SOARS) program. The trial aims to develop a reliable outpatient program that integrates well with primary care settings. It seeks participants who have recently experienced serious suicidal thoughts or a suicide attempt and are open to therapy. As an unphased trial, this study provides a unique opportunity to contribute to developing effective treatments for youth in crisis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the CAMS (Collaborative Assessment and Management of Suicidality) approach is both well-received and effective in managing suicide risk among teenagers. Studies have found CAMS to be successful in lowering suicide risk in teens by using tools like the Suicide Status Form to understand and address suicidal thoughts.
In this trial, the CAMS Single Session Consultation has reduced suicide risk. This method, supported by evidence, has been safely used in many settings. Training for caregivers and skills training for teens, which includes emotional and communication skills, strengthen the treatment. These components are based on well-known therapies like Dialectical Behavior Therapy (DBT) and Cognitive Behavioral Therapy (CBT), which are proven to be safe and effective.
Lethal Means Safety, which involves limiting access to items that could be used for self-harm, is also a crucial part of these treatments. This strategy has been shown to lower suicide risk by increasing the time and distance between a person and harmful means.
Overall, these treatments are considered safe and have been effectively used in similar situations to help reduce suicide risk in young people.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer innovative approaches to managing youth suicide risk. Unlike traditional treatments that might primarily focus on medication or long-term therapy, this trial combines brief, targeted interventions with skill-building. The treatments focus on immediate engagement through a single session of CAMS (Collaborative Assessment and Management of Suicidality), followed by either caregiver skills training, youth-focused skills training, or both. Additionally, some arms emphasize lethal means safety, providing families with tools to manage home safety. These approaches aim to stabilize crises quickly and equip both youth and caregivers with practical skills, potentially transforming the way we address acute suicide risk in young people.
What evidence suggests that this trial's treatments could be effective for youth suicide risk?
Research shows that the Collaborative Assessment and Management of Suicidality (CAMS) approach effectively reduces suicidal thoughts. Studies have found that CAMS can quickly decrease these thoughts in just 6 to 8 sessions. In this trial, participants will receive different combinations of interventions. One arm includes skills training for caregivers, which has shown positive results in helping families communicate better and handle crises. Another arm focuses on Lethal Means Safety, which involves limiting access to items that could be used for self-harm, thereby reducing suicide risks. By combining these methods, especially with skills training for both young people and their caregivers, this trial aims to provide a comprehensive solution to youth suicide risk. Various clinical studies support this combination, showing a decrease in suicidal thoughts and behaviors among adolescents.12367
Who Is on the Research Team?
Molly Adrian, Ph.D.
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for young people who have recently had suicidal thoughts or attempted suicide, as indicated by positive responses on the Ask Suicide Screening Questionnaire. It's designed to help improve outpatient care for acute youth suicide risk.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a minimum of 1 session and a maximum of 8 sessions of CAMS and additional components like coping skills training, caregiver skills, and lethal means safety
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, 1 month, and 2 months
What Are the Treatments Tested in This Trial?
Interventions
- Swift Outpatient Alternatives for Rapid Stabilization
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator